You May Not Be Receiving the Most Accurate Information About Autism Drugs
New research claims there's a bias when it comes to publishing studies about autism drugs.
An article in Pediatrics finds that positive results on serotonin receptor inhibitors, or SRIs are more likely to be published.
The drugs are used to treat repetitive behaviors, which are a hallmark of autism.
The authors found there were several unpublished studies that didn't show a significant benefit.
The authors say the results of all completed trials should be disclosed... not just the positive ones.